YS Biopharma Co. Ltd. (YS)
1.02
0.09 (9.68%)
At close: May 24, 2024, 8:00 PM
1.07
4.90%
After-hours: May 24, 2024, 07:20 PM EDT
9.68% (1D)
| Bid | 1.01 |
| Market Cap | 192.09M |
| Revenue (ttm) | 619.72M |
| Net Income (ttm) | -305.38M |
| EPS (ttm) | -0.56 |
| PE Ratio (ttm) | -1.8214285714285714 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.02 |
| Volume | 102,955 |
| Avg. Volume (20D) | 130,559 |
| Open | 0.90 |
| Previous Close | 0.93 |
| Day's Range | 0.90 - 1.10 |
| 52-Week Range | 0.35 - 1.78 |
| Beta | 0.54 |
About YS
YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 5, 2021
Employees 773
Stock Exchange NASDAQ
Ticker Symbol YS
Website https://www.yishengbio.com